BSECompany Update▲ PositiveResults31 Jul 2026
Tata Power Company Ltd
Announcement under Regulation 30(LODR) - Earnings Call Transcripts for Q1 FY27.
Tata Power Company Ltd has announced its Q1 FY27 earnings, with a 11% increase in PAT to INR 1,401 crores and an 8% increase in EBITDA to INR 4,249 crores. The company has also seen a strong demand growth in the power sector, with a 8.5% increase in power demand in the first quarter.
BSECompany Update▲ PositiveResults31 Jul 2026
KFin Technologies Ltd
Please find attached Transcript of Earnings Conference Call held on July 27, 2026
KFin Technologies Ltd published the transcript of its Earnings Conference Call for Q1 FY '27, highlighting its continued growth and resilience in the face of market volatility. The company's revenue has increased manifold over the past five years, driven by geographical diversification, asset class diversification, and business process diversification. The company's performance exudes confidence for the future, despite negligible or negative mark-to-market gains in the previous quarter.
NSEPress Release▲ PositiveResults31 Jul 2026
Clean Max Enviro Energy Solutions Limited
Press Release
Clean Max Enviro Energy Solutions Limited has announced its Q1 FY27 financial results, with revenue from operations more than doubling year-on-year to INR 832 crore, and Adjusted EBITDA growing 74% YoY to INR 494 crore. The company's contracted RE Power Sales capacity reached 6 GW as of June 30, 2026, and its total contracted portfolio stood at 6.8 GW.
BSECompany Update▲ PositiveExpansion31 Jul 2026
Aerpace Industries Ltd
Business Update for the month of July, 2026
Aerpace Industries Ltd announces business update for July 2026, introducing new leadership roles and strengthening its ecosystem across autonomous governance, aviation, intelligent energy, and long-term growth.
BSECompany Update▲ PositiveResults31 Jul 2026
Remi Edelstahl Tubulars Ltd
Earing Presentation as attached
Remi Edelstahl Tubulars Ltd has released its earnings presentation for Q1FY27, showcasing a revenue of ₹45.14 LAKHS and Profit After Tax of ₹3,537.17 LAKHS. The company has a strong order book of ₹114 Crs, including multiple export orders and new customer wins.
NSEPress Release▲ PositiveResults31 Jul 2026
Narayana Hrudayalaya Ltd.
Press Release
Narayana Hrudayalaya Ltd. has announced its Q1 FY27 results, with consolidated operating revenue at ₹ 26,836 Mn (YoY growth of 78.0%) and EBITDA of ₹ 5,052 Mn (YoY growth of 40.0%).
BSECompany Update▲ PositiveResults31 Jul 2026
Narayana Hrudayalaya Ltd
Investor presentation for the quarter ended June 30, 2026.
Narayana Hrudayalaya Ltd has released an investor presentation for the quarter ended June 30, 2026, highlighting its operational and financial performance. The company reported a consolidated operating revenue of ₹ 26,836 Mn, a change of +78.0% YoY and +3.5% QoQ, and a consolidated EBITDA of ₹ 5,052 Mn at a margin of 18.8%. The company also provided details on its revenue mix, patient footfalls, and ICU occupied bed days.
NSEInvestor Presentation▲ PositiveResults31 Jul 2026
CORONA Remedies Limited
Investor Presentation
CORONA Remedies Limited has released an investor presentation for Q1 FY27, highlighting its operational and financial performance, including revenue growth, improved rankings, and EU-GMP certification for its facilities.
BSECompany Update▲ PositiveResults31 Jul 2026
Narayana Hrudayalaya Ltd
Press release for the quarter ended June 30, 2026.
Narayana Hrudayalaya Ltd has announced its Q1 FY27 results, with consolidated operating revenue at ₹ 26,836 Mn, a YoY growth of 78.0%, and EBITDA of ₹ 5,052 Mn, a YoY growth of 40.0%. The company has also highlighted various achievements in its healthcare services, including 2,137 cardiac surgeries and the operationalization of new medical equipment.
BSECompany Update▲ PositiveResults31 Jul 2026
Corona Remedies Ltd
Analyst/Investor presentation
CORONA Remedies Ltd has released an investor presentation for Q1 FY27, highlighting its operational and financial performance, including revenue growth, improved ranking in the IPM, and EU-GMP certification for its Oral Solid Dosage facility.
NSEInvestor Presentation▲ PositiveResults31 Jul 2026
Narayana Hrudayalaya Ltd.
Investor Presentation
Narayana Hrudayalaya Ltd. has released its investor presentation for Q1 FY27, highlighting its operational and financial performance. The company reported a 78.0% YoY increase in consolidated operating revenues to ₹ 26,836 Mn and a 18.8% EBITDA margin. Narayana Health has expanded its footprint with new facilities and services, including robotic surgery capabilities.
BSEBoard Meeting▲ PositiveResults31 Jul 2026
Aarti Drugs Ltd
Financial Results for the quarter ended June 30, 2026
Aarti Drugs Ltd announced its audited standalone and consolidated financial results for the quarter ended June 30, 2026, with a profit before exceptional items and tax of ₹6,994. The company reported a revenue from operations of ₹70,278 and a total income of ₹72,030. The financial results were approved by the Board of Directors in their meeting held on July 31, 2026.
BSECompany Update▲ PositiveResults31 Jul 2026
Glenmark Pharmaceuticals Ltd
Investor Presentation - Q1 FY 26-27
Glenmark Pharmaceuticals Ltd has reported Q1 FY27 results with consolidated revenue of Rs. 40,185 million, a 23.1% YoY growth, driven by broad-based growth across key markets, with India, North America, and Emerging Markets delivering strong performance.
NSEUpdates▲ PositiveResults31 Jul 2026
Glenmark Pharmaceuticals Limited
Updates
Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Investor Presentation' for Q1 FY 27, with consolidated revenue of Rs. 40,185 million, a 23.1% YoY growth, and EBITDA of Rs. 8,048 million with a margin of 20.03%. The company has reported strong growth across its key markets, with India business growth of 15.5%, North America core business growth of 19.8%, and Emerging Markets business growth of 27.7%. The results reinforce the direction of Glenmark's next phase: strengthening its core businesses while expanding its differentiated specialty and innovation-led platforms.
NSEPress Release▲ PositiveResults31 Jul 2026
Glenmark Pharmaceuticals Limited
Press Release
Glenmark Pharmaceuticals Limited has announced its Q1 FY27 results, with consolidated revenue growing 23.1% YoY to Rs. 40,185 million, driven by strong execution and resilience of its business. The company reported EBITDA of Rs. 8,048 million, a 38.6% YoY growth, and PAT of Rs. 4,828 million, with a PAT margin of 11.8%. The company's India formulations revenue grew 15.5% YoY, North America revenue grew 41.1% YoY, and Emerging Markets revenue grew 27.7% YoY.
BSECompany Update▲ PositiveResults31 Jul 2026
Glenmark Pharmaceuticals Ltd
Please find attached Press Release and Management Discussion & Analysis for the first quarter ended June 30, 2026
Glenmark Pharmaceuticals Ltd has announced its Q1 FY27 results, with consolidated revenue growing 23.1% YoY to Rs. 40,185 million, driven by strong growth in India, North America, and Emerging Markets. EBITDA was Rs. 8,048 million, with a margin of 20.03%, and PAT was Rs. 4,828 million, with a margin of 11.8%. The company has also highlighted its focus on strengthening its core businesses and expanding its specialty and innovation-led platforms.
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026
Blue Dart Express Limited
Outcome of Board Meeting
Blue Dart Express Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditors. The results include a net profit of ₹8,668 and a dividend of ₹25 per equity share for the financial year ended March 31, 2026.
BSECompany Update▲ PositiveOrder Win31 Jul 2026
Powerica Ltd
Execution of Power Purchase Agreement
Powerica Ltd has executed a Power Purchase Agreement with Gujarat Urja Vikas Nigam Limited to set up a 100 MW Wind power project in Gujarat at a tariff of Rs. 3.435 per kWh for 25 years.
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win31 Jul 2026
Powerica Limited
Bagging/Receiving of orders/contracts
Powerica Limited has executed a Power Purchase Agreement with Gujarat Urja Vikas Nigam Limited to set up a 100 MW Wind power project in Gujarat at a tariff of Rs. 3.435 per kWh for 25 years.
NSEPress Release▲ PositiveResults31 Jul 2026
Yasho Industries Limited
Press Release
Yasho Industries Limited has announced its unaudited financial results for Q1 FY27, with revenue of ₹307.74Cr, a 42% YoY increase, driven by additional off-take by existing customers and acquisition of marquee international customers. EBITDA margin improved to 24.2% and PAT margin to 11.7%, driven by optimized product mix, cost discipline, and operating efficiencies.